Bioventus
BVS
BVS
67 hedge funds and large institutions have $109M invested in Bioventus in 2023 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 26 increasing their positions, 18 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 66 → 67 (+1)
1.36% more ownership
Funds ownership: 51.2% → 52.55% (+1.4%)
8% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 13
Holders
67
Holding in Top 10
3
Calls
$658K
Puts
$270K
Top Buyers
| 1 | +$1.32M | |
| 2 | +$991K | |
| 3 | +$641K | |
| 4 |
JIC
Juniper Investment Company
New York
|
+$584K |
| 5 |
KLC
Kent Lake Capital
Reno,
Nevada
|
+$446K |
Top Sellers
| 1 | -$1.18M | |
| 2 | -$400K | |
| 3 | -$379K | |
| 4 |
E
Ergoteles
New York
|
-$228K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$223K |